GSTM1 and hypogonadism: To assess the impact of overt hypogonadism, overt hypothyroidism (primary or secondary), prolactin change from diagnosis, age, smoking, and hormone replacement therapies (glucocorticoids, thyroid hormones, estrogen) on RBC, HCT and Hb at PRL normalization, a multivariable regression was performed.